MVT: In the News
Search
- Feb 28
Timothy Healey Joins the Board of Directors at Microvascular Therapeutics
Microvascular Therapeutics (MVT), a clinical stage biotechnology company based in Tucson, Arizona, announced the appointment of Timothy...
- Feb 8
ImaRx Investments Receives ISO-7 Certification for Its GMP Manufacturing Suite
ImaRx Investments, LLC, an investment firm based in Tucson, Arizona, has received ISO-7 certification on February 1st for its GMP...
- Dec 22, 2020
Microvascular Therapeutics enters licensing agreement with UNC Chapel Hill and Columbia University
Microvascular Therapeutics (MVT) has entered into a licensing agreement with the University of North Carolina at Chapel Hill and Columbia...
- Aug 1, 2020
Microvascular Therapeutics receives NIH SBIR Phase I funds for its Alzheimer program
Tucson, Arizona, August 1st, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...
- Jul 21, 2020
Microvascular Therapeutics receives NIH SBIR Phase I funds for its program to treat heart attack
Tucson, Arizona, July 22nd, 2020: Microvascular Therapeutics (MVT), a biotechnology company based in Tucson, AZ, was recently awarded a...
- Jul 9, 2018
Microvascular Therapeutics Licenses Patent from Triangle Biotechnology Inc.
Microvascular Therapeutics (MVT), LLC, a privately-held Tucson-based biotechnology company, has licensed a patent from Triangle...
- Mar 29, 2018
MVT Receives $1.7M Grant from National Heart, Lung, and Blood Institute of Health
Microvascular Therapeutics (MVT), a Tucson based biotechnology company, announced that it has been awarded a $1.7M grant from the...
- Oct 31, 2017